{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/atrial-fibrillation/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"f65a3e88-8f57-5c09-867a-ba88262e838c","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 79ba37c9-02fb-4361-975b-2cf911834819 --><h2>Update</h2><!-- end field 79ba37c9-02fb-4361-975b-2cf911834819 -->","summary":null,"htmlStringContent":"<!-- begin item 6f4cd42e-f85c-401a-88ad-cd0b863f31a1 --><!-- end item 6f4cd42e-f85c-401a-88ad-cd0b863f31a1 -->","topic":{"id":"c61747eb-a307-5da3-9878-9e952f2e1246","topicId":"e42fc175-7ae7-44c7-b7ef-b58a14733e7e","topicName":"Atrial fibrillation","slug":"atrial-fibrillation","lastRevised":"Last revised in October 2020","chapters":[{"id":"15747365-1cc2-550f-ad60-639db7df4ff0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9ced6fef-0141-5375-b1c4-37d2756e7678","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"75cb268e-28e7-51c1-87dd-0a86fbc0616b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1390db2e-6367-52cb-9af5-792d2e4d9310","slug":"changes","fullItemName":"Changes"},{"id":"f65a3e88-8f57-5c09-867a-ba88262e838c","slug":"update","fullItemName":"Update"}]},{"id":"16591b01-3ee5-5b14-a7e2-7a5226294933","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f3967a51-562c-5a5b-b55a-02dd39bfcbe9","slug":"goals","fullItemName":"Goals"},{"id":"5a66a5f8-9497-5664-abc1-d16cfe63bdd4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0ca3b265-f279-56a1-94f0-c0e96dbeaaff","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8bf96582-45d8-507c-9772-4c1092b4bd6a","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"992b55c8-2134-5283-b0f7-34608af53bd1","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"677bafba-be09-57b3-a169-096ee3aa3fa1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b6e491b1-6724-5c59-b127-fc29812ea52f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"dab901c7-1cc0-5253-a4e0-e5b5bc04ba5e","slug":"definition","fullItemName":"Definition"},{"id":"39c5efdc-48cc-5b0a-85d7-f7da2de67a25","slug":"causes","fullItemName":"Causes"},{"id":"211e1811-bd20-5cfb-b7b9-c06c3fd223a3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"96a3b3f8-183a-52b6-9909-a81f0fd999dd","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"fc0c1acd-3cda-53a5-85ae-be117589c6bb","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0a1e6d67-1c9c-5ea9-a30c-006e32e641c7","slug":"diagnosis-of-atrial-fibrillation","fullItemName":"Diagnosis of atrial fibrillation"}]},{"id":"42efe54e-8ff7-5283-ad5f-7dabdd2dcdff","fullItemName":"Management","slug":"management","subChapters":[{"id":"a955511a-8fbf-5bf9-aa82-b0e634a6325b","slug":"management-of-af","fullItemName":"Scenario: Management of AF"}]},{"id":"c2a59ca9-6ff7-533b-912e-d7ba0cc5fcb9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a2c20504-f7cb-54cc-adc0-c0cb70ec0ccb","slug":"beta-blockers-except-sotalol","fullItemName":"Beta-blockers (except sotalol)"},{"id":"d02a47f9-0498-503c-9cb1-0c3f89766d4f","slug":"diltiazem-verapamil","fullItemName":"Diltiazem and verapamil"},{"id":"037e75e8-454f-5dcd-a0b8-3e9ff5a5b309","slug":"digoxin","fullItemName":"Digoxin"},{"id":"c0c53c1d-4cd9-5e70-8a01-3d5f59d213cb","slug":"anticoagulants","fullItemName":"Anticoagulants"},{"id":"49e47ec1-0743-51db-a133-a2eed45d0eb0","slug":"aspirin-clopidogrel","fullItemName":"Aspirin and clopidogrel"},{"id":"5cb461d2-9502-5698-a467-30edd459c1b3","slug":"amiodarone-not-initiated-in-primary-care","fullItemName":"Amiodarone - not initiated in primary care"},{"id":"0fae1520-f160-57a2-af90-5b46bb20bdf5","slug":"sotalol-not-initiated-in-primary-care","fullItemName":"Sotalol - not initiated in primary care"}]},{"id":"1048ec97-41b1-5f93-a54d-1f58a8a56528","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5fff0dc2-1e01-590e-a159-76736c6a2ac0","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b4497d2f-172b-54a5-99c6-5cd92c8469ba","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d1d9c4e5-758a-5a99-93e3-4d2099a68d60","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0b86c2fd-54d8-569a-a8a8-ccadd53c17a0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e7ea1b2f-6198-53f7-b4f8-681296a03562","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3a114d83-bf8b-5507-b946-6af4f46c529e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5bbaf83e-cca2-55f4-a4c9-e6b808387a89","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"75cb268e-28e7-51c1-87dd-0a86fbc0616b","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"1e067e37-4bbb-5b5b-af9f-9a5a0ab65603","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 233aa528-3b5e-4472-b444-3dacffe621e8 --><h3>New evidence</h3><!-- end field 233aa528-3b5e-4472-b444-3dacffe621e8 -->","summary":null,"htmlStringContent":"<!-- begin item 7da91126-20eb-423e-92b8-3e2b94179567 --><!-- begin field fe01a1b0-0758-44f0-a2f7-e4f54ff703cd --><h3>Evidence-based guidelines</h3><!-- end field fe01a1b0-0758-44f0-a2f7-e4f54ff703cd --><!-- begin field 48f37efd-0faa-46b5-b53e-ce769a46d3db --><ul><li>Upadhyay, G. A. and Alenghat, F. (2019) <em>Catheter Ablation for Atrial Fibrillation in 2019.</em> JAMA Network. <a href=\"https://jamanetwork.com/\" data-hyperlink-id=\"8ea17167-e007-48ca-a39b-aab2009388e6\">www.jamanetwork.com</a> [<a href=\"https://jamanetwork.com/journals/jama/article-abstract/2748494\" data-hyperlink-id=\"a57cbe1b-7fee-4031-b299-aab2009389a2\">Abstract</a>]</li><li>Sulzgruber, P., Wassmann, S., Semb, A., et al (2019) <em>Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA<sub>2</sub>DS<sub>2</sub>-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.</em> European Heart Journal. <a href=\"https://academic.oup.com/journals\" data-hyperlink-id=\"ff4f6732-9590-4189-9cc0-aae200c47527\">www.academic.oup.com</a> [<a href=\"https://academic.oup.com/eurheartj/article/40/36/3010/5572090\" data-hyperlink-id=\"0a4cc123-580a-44bb-bae5-aae200c478f8\">Free Full-text</a>]</li><li>Chung, M.K., Eckhardt, L.L., Chen, L.Y. et al. (2020) <em>Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association.</em> Circulation. <a href=\"https://www.ahajournals.org/\" data-hyperlink-id=\"13236b53-2df3-41d1-93c5-ab8800881538\">www.ahajournals.org</a> [<a href=\"https://www.ahajournals.org/doi/10.1161/CIR.0000000000000748\" data-hyperlink-id=\"48e8bb9a-9a92-4aa3-80e2-ab88008816e7\">Free full-text</a>]</li><li>Hindricks, G., Potapara, T., Dagres, et al. (2020). <em>2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).</em> European Heart Journal. <a href=\"https://academic.oup.com/journals\" data-hyperlink-id=\"e567b734-5395-43f2-b6b1-ac2c00af5e7a\">www.academic.oup.com</a> [<a href=\"https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa612/5899003\" data-hyperlink-id=\"ec75cd1b-0e3d-43b2-aedc-ac2c00af5fdf\">Free Full-text</a>]</li></ul><!-- end field 48f37efd-0faa-46b5-b53e-ce769a46d3db --><!-- begin field 281f3040-b688-41d3-9cb9-d8067eb872c9 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 281f3040-b688-41d3-9cb9-d8067eb872c9 --><!-- begin field 695c62f7-6f93-4c4d-9ac7-b86014f1eb75 --><p>No new HTAs since 1 May 2019.</p><!-- end field 695c62f7-6f93-4c4d-9ac7-b86014f1eb75 --><!-- begin field 1c7fcc16-3fd5-4c20-97b9-6ed008a0f4fc --><h3>Economic appraisals</h3><!-- end field 1c7fcc16-3fd5-4c20-97b9-6ed008a0f4fc --><!-- begin field fe99e828-0033-4d99-bd91-7a7df88ffab9 --><p>No new economic appraisals since 1 May 2019.</p><!-- end field fe99e828-0033-4d99-bd91-7a7df88ffab9 --><!-- begin field 57cfe7ee-cfb9-49c4-959c-149be8db78a2 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 57cfe7ee-cfb9-49c4-959c-149be8db78a2 --><!-- begin field edd685cf-a75b-48d7-a16f-161db9c6f94f --><ul><li>Khan, S.U., Osman, M., Khan, M.U. et al (2020) <em>Dual versus triple therapy for atrial fibrillation after percutaneous coronary intervention: a systematic review and meta-analysis.</em> Annals of Internal Medicine. <a href=\"http://www.annals.org/\" data-hyperlink-id=\"e1c176d5-7007-4d29-a444-ab8800992eb0\">www.annals.org</a> [<a href=\"https://annals.org/aim/article-abstract/2763089/dual-versus-triple-therapy-atrial-fibrillation-after-percutaneous-coronary-intervention\" data-hyperlink-id=\"af318095-9396-47fc-a13c-ab8800992ffe\">Abstract</a>]</li></ul><!-- end field edd685cf-a75b-48d7-a16f-161db9c6f94f --><!-- begin field 5ee7d306-d001-4c54-aeac-a59fb77a5d2d --><h3>Primary evidence</h3><!-- end field 5ee7d306-d001-4c54-aeac-a59fb77a5d2d --><!-- begin field 9a9cf5e0-e599-469c-b4f0-16714f4b5163 --><ul><li>Rodriquez, L.A.G., Soriano, L.C., Hald, S.M., et al. (2020) <em>Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke. </em>Heart. <a href=\"https://heart.bmj.com/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"20ddf055-d82f-4863-ab4b-ac9500b16493\">www.heart.bmj.com</a> [<a href=\"https://heart.bmj.com/content/early/2020/12/10/heartjnl-2020-317887\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"813903ff-f027-44ba-9179-ac9500b16493\">Free Full-text</a>]</li></ul><!-- end field 9a9cf5e0-e599-469c-b4f0-16714f4b5163 --><!-- end item 7da91126-20eb-423e-92b8-3e2b94179567 -->","subChapters":[]},{"id":"0c41c0f0-3839-5c46-b7d2-ca646575de3b","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 1a7aa978-5d7f-4b81-a415-b37e8a2e9c3f --><h3>New policies</h3><!-- end field 1a7aa978-5d7f-4b81-a415-b37e8a2e9c3f -->","summary":null,"htmlStringContent":"<!-- begin item 45899653-cb87-4e38-8366-ec262980b30f --><!-- begin field fe401250-2aeb-4d83-9b12-36f68e4bb9ee --><p>No new national policies or guidelines since 1 May 2019.</p><!-- end field fe401250-2aeb-4d83-9b12-36f68e4bb9ee --><!-- end item 45899653-cb87-4e38-8366-ec262980b30f -->","subChapters":[]},{"id":"848093fc-1566-5ac4-bd55-9e0e4f39c98e","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 1fb8af15-ae96-449a-9cd9-26f6690d93c4 --><h3>New safety alerts</h3><!-- end field 1fb8af15-ae96-449a-9cd9-26f6690d93c4 -->","summary":null,"htmlStringContent":"<!-- begin item 9e0901cb-79af-4aa4-aa75-3819e70075da --><!-- begin field 8a6121e6-f05a-469c-806b-310e2a491140 --><p>No new safety alerts since 1 May 2019.</p><!-- end field 8a6121e6-f05a-469c-806b-310e2a491140 --><!-- end item 9e0901cb-79af-4aa4-aa75-3819e70075da -->","subChapters":[]},{"id":"de48b41d-fa91-53c0-a2cb-739130b916c7","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field ee61475a-a727-4d2a-8ad3-f601a9f76683 --><h3>Changes in product availability</h3><!-- end field ee61475a-a727-4d2a-8ad3-f601a9f76683 -->","summary":null,"htmlStringContent":"<!-- begin item 8281b3e6-fb44-4183-b87c-a305ee78c5c2 --><!-- begin field 0f1c77ed-f68e-4222-a8f7-b02f0191269f --><p>No new changes in product availability since 1 May 2019.</p><!-- end field 0f1c77ed-f68e-4222-a8f7-b02f0191269f --><!-- end item 8281b3e6-fb44-4183-b87c-a305ee78c5c2 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}